Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.65 and traded as low as $1.21. Check-Cap shares last traded at $1.21, with a volume of 36,736 shares traded.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Check-Cap in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.
Check Out Our Latest Stock Report on CHEK
Check-Cap Trading Down 10.4%
About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
See Also
- Five stocks we like better than Check-Cap
- What is MarketRank� How to Use it
- CAVA Stock Looking for Direction After Earnings Miss
- What is the Nasdaq? Complete Overview with History
- 3 Small AI Stocks Ready to Explode (All Under $20)
- Business Services Stocks Investing
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.
